RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Capital expenditures

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.4B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-45+90.21%
Dec 31, 2023-24+51.42%
Dec 31, 2022-16+31.50%
Dec 31, 2021-12-65.96%
Dec 31, 2020-35+13.64%
Dec 31, 2019-31+127.11%
Dec 31, 2018-14-60.86%
Dec 31, 2017-35+389.15%
Dec 31, 2016-7-7.61%
Dec 31, 2015-8+2.31%
Dec 31, 2014-8+384.41%
Dec 31, 2013-2+4.94%
Dec 31, 2012-1-79.83%
Dec 31, 2011-7-44.62%
Dec 31, 2010-13

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)